Use of an anti-human tnf-alpha monoclonal antibody in the...

Details Use of an anti-human tnf-alpha monoclonal antibody in the... Use of an anti-human tnf-alpha monoclonal antibody in the...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 31/40 (2006.01) A61K 31/4015 (2006.01) A61K 31/404 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) A61K 31/52 (2006.01) A61K 31/522 (2006.01) A61K 38/19 (2006.01) A61K 47/48 (2006.01) C07K 14/715 (2006.01) C07K 16/24 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2246297

A method of treating or preventing a cardiovascular and/or a cerebrovascular disorder in an individual is disclosed. Also disclosed is a method for treating and/or preventing a thrombotic disorder in an individual. Further disclosed is a method of decreasing plasma fibrinogen in an individual.

L'invention concerne un procédé de traitement ou de prévention d'une maladie cardio-vasculaire et/ou cérébrovasculaire affectant un individu. L'invention se rapporte également à un procédé de traitement et/ou de prévention d'une maladie thrombotique affectant un individu, ainsi qu'à un procédé de réduction du fibrinogène du plasma chez un individu.

Affiliated with

Also associated with

Rating

Use of an anti-human tnf-alpha monoclonal antibody in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of an anti-human tnf-alpha monoclonal antibody in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an anti-human tnf-alpha monoclonal antibody in the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2022114